Showing results (1891-1900 of 2,771) with videos related to
Sort By:
Pageof 278
American Journal of Therapeutics|March 22, 2024
Psychedelic Therapy: A Primer for Primary Care Clinicians-The Strengths, Weaknesses, Opportunities, and Threats of Psychedelic TherapeuticsOwen S Muir, Kenneth Shinozuka, Bryce D Beutler, et al.American Journal of Therapeutics|March 22, 2024
Psychedelic Therapy: A Primer for Primary Care Clinicians-Lysergic Acid Diethylamide (LSD)Bryce D Beutler, Kenneth Shinozuka, Burton J Tabaac, et al.American Journal of Therapeutics|March 22, 2024
Psychedelic Therapy: A Primer for Primary Care Clinicians-3,4-Methylenedioxy-methamphetamine (MDMA)Kenneth Shinozuka, Burton J Tabaac, Alejandro Arenas, et al.American Journal of Therapeutics|March 22, 2024
Psychedelic Therapy: A Primer for Primary Care Clinicians-KetamineViviana D Evans, Alejandro Arenas, Kenneth Shinozuka, et al.American Journal of Therapeutics|March 22, 2024
Psychedelic Therapy: A Primer for Primary Care Clinicians-PsilocybinBurton J Tabaac, Kenneth Shinozuka, Alejandro Arenas, et al.Journal of Cognitive Engineering and Decision Making|October 7, 2020
Value and Usage of a Workaround Artifact: A Cognitive Work Analysis of "Brains" Use by Hospital NursesAustin F Mount-Campbell, Kevin D Evans, David D Woods, et al.Computer Methods and Programs in Biomedicine|September 4, 2010
Indistinguishability and identifiability of kinetic models for the MurC reaction in peptidoglycan biosynthesisJ G Hattersley, J Pérez-Velázquez, M J Chappell, et al.Ecological Applications : a Publication of the Ecological Society of America|September 25, 2019
Long-term dynamics and drivers of coral and macroalgal cover on inshore reefs of the Great Barrier Reef Marine ParkDaniela M Ceccarelli, Richard D Evans, Murray Logan, et al.The Knee|February 18, 2019
Clinical measures associated with knee function over two years in young athletes after ACL reconstructionMatthew P Ithurburn, Mark V Paterno, Staci Thomas, et al.Cancer Chemotherapy and Pharmacology|June 15, 1999
Metabolism of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in cancer patients undergoing a phase I clinical trialP C Schofield, I G Robertson, J W Paxton, et al.Pageof 278